Long-term Safety, Efficacy, Treatment Satisfaction, and Impact on Healthcare Service Use of Paliperidone Palmitate One-month Intramuscular Formulation in Patients with Recent-onset Schizophrenia in Taiwan: A Subgroup Analysis of an Asia-Pacific, 18-month, Phase 3b Study_

:::

詳目顯示

第 1 筆 / 總合 1 筆

/1頁

來源文獻資料
引文資料

題名：	Long-term Safety, Efficacy, Treatment Satisfaction, and Impact on Healthcare Service Use of Paliperidone Palmitate One-month Intramuscular Formulation in Patients with Recent-onset Schizophrenia in Taiwan: A Subgroup Analysis of an Asia-Pacific, 18-month, Phase 3b Study
書刊名：	Taiwanese Journal of Psychiatry
作者：	Tang, Tze-chun／Hsieh, Ming-hong／Liu, Chen-chung／Chiu, Nan-ying／Jang, Fong-lin／Chiang, Chih-lin／Su, Tung-ping
出版日期：	2019
卷期：	33:4
頁次：	頁198-203
主題關鍵詞：	Clinical trial；Employment status；Long-acting injection；Schizophrenia
原始連結：	連回原系統網址
相關次數：	被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0) 排除自我引用:0 共同引用:0 點閱:4

期刊論文
1.	Chiang, C. L.、Chen, P. C.、Huang, L. Y.(2016)。Impact of universal health coverage on urban-rural inequity in psychiatric service utilisation for patients with first admission for psychosis: a 10-year nationwide population-based study in Taiwan。BMJ Open，6。
2.	Chi, M. H.、Hsiao, C. Y.、Chen, K. C.(2016)。The readmission rate and medical cost of patients with schizophrenia after first hospitalization-a 10-year follow-up population-based study。Schizophrenia Research，170，184-190。
3.	Lêng, C. H.、Chou, M. H.、Lin, S. H.、Yang, Y. K.、Wang, J. D.(2016)。Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan。Schizophrenia Research，171，97-102。
4.	Pan, Y. J.、Kuo, K. H.、Yeh, L. L.(2019)。Healthcare cost, service use and mortality in major psychiatric disorders in Taiwan。J Affect Disord，246，112-120。
5.	Jin, H.、Mosweu, I.(2017)。The societal cost of schizophrenia: a systematic review。Pharmacoeconomics，35，25-42。
6.	Millier, A.、Schmidt, U.、Angermeyer, M. C.(2014)。Humanistic burden in schizophrenia: a literature review。J Psychiatr Res，54，85-93。
7.	Lo, T. L.、Warden, M.、He, Y.(2016)。Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region。Asia Pac Psychiatry，8，154-171。
8.	Olivares, J. M.、Thirunavukarasu, M.、Kulkarni, J.(2013)。Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-pacific survey。Neuropsychiatr Dis Treat，9，1163-1170。
9.	Huang, Si-sheng、Chang, Cheng-chen(20190400)。Comparison of Insight in Patients with Schizophrenia, Bipolar I Disorder, and Major Depressive Disorder in a Real-world Setting。Taiwanese Journal of Psychiatry，33(2)，92-98。
10.	Birnbaum, M.、Sharif, Z.(2008)。Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER。Patient Prefer Adherence，2，233-240。
11.	Malla, A.、Tibbo, P.、Chue, P.(2013)。Long-acting injectable antipsychotics: recommendations for clinicians。Can J Psychiatry，58，30S-35S。
12.	Samalin, L.、Abbar, M.、Courtet, P.(2013)。French society for biological psychiatry and neuropsychopharmacology task force: formal consensus for the prescription of depot antipsychotics。Encephale，39(Suppl 4)，189-203。
13.	Schreiner, A.、Bergmans, P.、Cherubin, P.(2015)。Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics。J Psychopharmacol，29，910-922。
14.	Zhang, F.、Si, T.、Chiou, C. F.(2015)。Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia。Neuropsychiatr Dis Treat，11，657-668。
15.	Alphs, L.、Bossie, C. A.、Sliwa, J. K.(2013)。Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics。Neuropsychiatr Dis Treat，9，341-350。
16.	Wallwork, R. S.、Fortgang, R.、Hashimoto, R.(2012)。Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia。Schizophr Res，137，246-250。
17.	Zhang, H.、Turkoz, I.、Zhuo, J.(2017)。Paliperidone palmitate improves and maintains functioning in Asia-pacific patients with schizophrenia。Adv Ther，34，2503-2517。
18.	Fu, D. J.、Turkoz, I.、Simonson, R. B.(2016)。Paliperidone palmitate oncemonthly injectable treatment for acute exacerbations of schizoaffective disorder。J Clin Psychopharmacol，36，372-376。
19.	Fu, D. J.、Turkoz, I.、Simonson, R. B.(2015)。Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder。J Clin Psychiatry，76，253-262。
20.	Turkoz, I.、Fu, D. J.、Bossie, C. A.(2015)。The direct and indirect effects of paliperidone extended-release on depressive symptoms in schizoaffective disorder: a path analysis。Innov Clin Neurosci，12，10-17。
21.	Taipale, H.、Mehtälä, J.、Tanskanen, A.(2018)。Comparative effectiveness of antipsychotic drugs for rehospitalization in schizophrenia--A nationwide study with 20-year follow-up。Schizophr Bull，44，1381-1387。
22.	Tiihonen, J.、Mittendorfer-Rutz, E.、Majak, M.(2017)。Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29823 patients with schizophrenia。JAMA Psychiatry，74，686-693。
23.	Kishimoto, T.、Nitta, M.、Borenstein, M.(2013)。Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies。J Clin Psychiatry，74，957-965。
24.	Su, K. P.、Chang, H. C.、Tsai, S. J.(2009)。Relapse and long-acting injectable risperidone: a 1-year mirror image study with a national claims database in Taiwan。Value Health，12(Suppl 3)，S118-S121。

推文
推薦
引用網址
引用嵌入語法
轉寄

top

:::

相關期刊
相關論文
相關專書
相關著作
熱門點閱

1.	Comparison of Insight in Patients with Schizophrenia, Bipolar I Disorder, and Major Depressive Disorder in a Real-world Setting

無相關博士論文

無相關書籍

無相關著作

1.	The Potential Use of Using the Psychological Side Effects of Antidepressants in Treating Cancer Patients
2.	Interpersonal Therapy Group for Middle-aged Depressive Patients: A Pilot Study
3.	Risk of Developing Migraine among Patients with Posttraumatic Stress Disorder: A Nationwide Longitudinal Study
4.	A History of Mental Health Care in Japan: International Perspectives
5.	The Moderator Rôle of Family Support between Depression and Suicidal Ideation: Discrepancy between Male and Female Military Population in Taiwan
6.	Avoidable Mortality among Long-stay Patients with Schizophrenia under Different Smoking-restriction Settings
7.	A Gene-gene Interaction between the Vascular Endothelial Growth Factor A and Brain-derived Neurotrophic Factor Genes Is Associated with Psychological Distress in the Taiwanese Population
8.	Effectiveness of Medical Service Quality Promotion Project for Child and Adolescent Patients with Mental Disabilities and Psychiatric Disorders in Taiwan
9.	Unmet Needs for the Management of Depression
10.	Banning Paraquat Would Prevent Nearly 200 Deaths from Suicide per Year in Taiwan
11.	Risk Factors of Psychiatric Hospitalization of Military Service Persons in Taiwan: Preliminary Results from Unsupervised Clustering Techniques
12.	The Correlations between Results of Short-form Wechsler Adult Intelligence Scale-III and Demographic/Clinical Factors in Patients with Schizophrenia: Preliminary Findings
13.	Maker Activities in a Psychiatric Day Care Center
14.	The Reinforcement Sensitivity of Male Adults with Attention-deficit/Hyperactivity Disorder: The Association with Internet Addiction
15.	A Gene-based Analysis of Variants in the Brain-derived Neurotrophic Factor Gene with Psychological Distress in a Taiwanese Population

QR Code

臺灣人文及社會科學引文索引資料庫系統

詳目顯示

臺灣人文及社會科學引文索引資料庫